Khanani AM, Danzig CJ, Heier JS, Jaffe GJ, et al. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 2-year efficacy and safety results from the GATHER2 phase 3 trial. Ophthalmology 2025 Dec 15:S0161-6420(25)00790.
PMID: 41407269